Purple Innovation accelerates termination of NOL poison pill to May 7, 2025

Purple Innovation, Inc.

Board accelerated expiration of NOL Rights Plan and NOL Charter Amendment to May 7, 2025 (from June 30, 2025).
Termination removes the right dividend that diluted acquirers, enabling larger share purchases.
Decision based on ownership change analysis and to avoid share price suppression during strategic review.
Series C Preferred Stock eliminated via Certificate of Elimination filed with Delaware Secretary of State.
NOL plan was adopted June 2024 to protect ~$238M in NOLs from Section 382 ownership change limits.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Purple Innovation, Inc.: Filed Certificate of Elimination to eliminate provisions of the Certificate of Designation for Series C Junior Participating Preferred Stock (effective 2025-05-07).

Change: charter amendment
Effective: 2025-05-07

Exact text from the filing

On May 6, 2025, the Company filed a Certificate of Elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware eliminating, effective as of 5:00 P.M., New York City time on May 7, 2025, all provisions of the Certificate of Designation previously filed by the Company with the Delaware Secretary of State on June 28, 2024 related to a series of preferred stock designated as Series C Junior Participating Preferred Stock established pursuant to the NOL Rights Plan.

View on SEC.gov

Browse all governance changes →

Purple Innovation, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-040154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.